ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627168 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627168; 2) Community: the network communities that were significantly associated with the response to NSC 627168; 3) Molecule: the relationships between components within communities and NSC 627168; 4) MDR: the compounds that were significantly associated with the NSC 627168.

NSC Compound Enrichment Correlation
NSC 302325 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- 0.0382675857669585 0.47208355
NSC 30706 2,5-Di(ethyleneimino)-1,4-benzoquinone 0.0382675857669585 0.24270956
NSC 606698 Rapamycin prodrug, Mono-(28)-N,N-dimethylglycinate-, methanesulfonic acid salt 0.0382675857669585 0.011173059
NSC 626167 Aplidazole C . TFA 0.0382675857669585 0.25344508
NSC 626669 Null 0.0382675857669585 0.39660615
NSC 758896 FLUVASTATIN 0.0382675857669587 0.062105723
NSC 631304 cis-Amminedichloro[2-(3,4-dimethoxyphenyl)ethylamine] platinum(II) 0.0382675857669588 0.27295033
NSC 632608 Diammine-1,7,10,16-tetraoxa-4,13-diazacyclooctadecane- platinum(II)dichloride 0.0382675857669588 -0.054868386
NSC 638199 Null 0.0382675857669588 0.36185252
NSC 639366 1-[[3'-(Diethylamino)-2'-hydroxypropyl]amino]-4- [(2'',3''-epoxypropyl)-amino-9,10-anthracenedione Fumaric Acid 0.0382675857669588 0.53661505
Total:81  Current:66    [First] [Prev] [Next] [Last]